합성생물학 시장 규모, 점유율, 예측, 동향 분석 : 제품(효소, 올리고뉴클레오티드, DNA)기술(유전자 합성, 유전체 편집, 시퀀싱, 클로닝)용도(생명과학, 화학, 식품)별 최종사용자별 시장 규모, 점유율, 전망, 동향 분석 및 예측(-2031년)

Synthetic Biology Market Size, Share, Forecast, & Trends Analysis by Product (Enzymes, Oligonucleotide, DNA) Technology (Gene Synthesis, Genome Editing, Sequencing, Cloning) Application (Life Sciences, Chemical, Food) End User - Global Forecast to 2031

US $ 4,175 ￦ 6,194,000

PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 파일 내 텍스트 등의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.

US $ 5,875 ￦ 8,716,000

PDF & Excel (Multi User License)

PDF & Excel 보고서를 동일 기업내 5명까지 이용할 수 있는 라이선스입니다. 파일 내 텍스트 등의 Copy & Paste 가능합니다. 5부까지 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.

US $ 7,875 ￦ 11,684,000

PDF & Excel (Global Site License)

PDF & Excel 보고서를 동일 기업 & 자회사의 모든 분이 이용할 수 있는 라이선스입니다. 파일 내 텍스트 등의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.

한글목차

이 보고서는 광범위한 2차 및 1차 연구와 합성생물학 시장 시나리오에 대한 심층 분석을 통해 주요 시장 동인, 과제 및 기회를 분석하여 작성되었습니다. 이 시장의 성장은 합성생물학 연구에 대한 자금 지원 증가, 시퀀싱 비용 감소, 합성생물학 응용 분야 확대, 유전공학 기술 발전, 합성 백신에 대한 연구 증가로 인해 발생할 수 있습니다. 그러나 합성생물학과 관련된 생물안전 및 생물보안 문제, 윤리적 문제가 시장 성장을 저해하는 요인으로 작용하고 있습니다.

또한, 연구개발 자금 증가, 개인 맞춤형 의료에 대한 관심 증가, 합성생물학 분야의 기술 혁신은 성장 기회를 가져올 것으로 예상됩니다. 그러나 합성생물학이 생태계에 미치는 전례 없는 영향과 합성생물학의 수용과 활용에 대한 대중의 소극적인 태도는 시장 성장에 큰 걸림돌로 작용하고 있습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 인사이트

• 개요
• 성장 촉진요인
• 성장 억제요인
• 기회
• 과제
• 요인 분석
• 동향
• 규제 분석
• Porter의 Five Forces 분석
• 투자와 자금조달 시나리오

제5장 합성생물학 시장 평가 : 제품별

• 개요
• Oligonucleotide and Synthetic DNA
• Xeno-nucleic Acids
• Enzymes
• Cloning Technology Kits
• Chassis Organism
• 기타 제품

제6장 합성생물학 시장 평가 : 기술별

• 개요
• 유전자 합성
• 시퀀싱(염기 배열 결정)
• 유전자 편집
• 클로닝
• 부위 특이적 돌연변이 유발
• 바이오인포매틱스
• 기타 기술

제7장 합성생물학 시장 평가 : 용도별

• 개요
• 생명과학 및 의료 용도
  • Drug Discovery
  • 바이오프로세스
  • 치료제
  • 기타 생명과학 및 의료 용도
• 산업 및 화학 용도
  • 바이오연료
  • 산업용 효소
    • 섬유 산업
    • 제지 산업
    • 화장품 산업
  • Bioplastics & Green Chemicals
• 식품 및 농업 용도
  • 특수 식품
  • 비료
• 환경 용도
  • 바이오센싱
  • 바이오레메디에이션/보전

제8장 합성생물학 시장 최종사용자별 평가

• 개요
• 제약/바이오테크놀러지/의료 기술(MedTech) 기업
• CMO 및 CRO
• 학술기관 및 연구기관
• 식품 및 농업
• 화학 산업
• 환경 기관
• 기타 최종사용자

제9장 합성생물학 시장 지역별 평가

• 개요
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 덴마크
  • 스위스
  • 기타 유럽(RoE)
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 기타 아시아태평양(RoAPAC)
• 라틴아메리카
  • 브라질
  • 멕시코
  • 기타 라틴아메리카(RoLATAM)
• 중동 및 아프리카

제10장 경쟁 분석

• 개요
• 주요 성장 전략
• 경쟁 벤치마킹
• 경쟁 대시보드
  • 업계 리더
  • 시장 차별화 요인
  • 선구 기업
  • 신규 기업
• 주요 기업의 시장 점유율 분석/시장 순위(2023년)

제11장 기업 개요(기업 개요, 재무 개요, 제품 포트폴리오, 전략 전개 상황)

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Novozymes A/S
• Codexis, Inc.
• Creative Biogene Inc.
• Amyris, Inc.
• Precigen, Inc.
• Illumina, Inc.
• New England Biolabs
• Ginkgo Bioworks
• Genscript Biotech Corp.
• Eurofins Scientific SE
• Twist Bioscience

(주 : 주요 5개사의 SWOT 분석을 게재)

제12장 부록

LSH

영문 목차

영문목차

The global synthetic biology market is Projected to Reach $80.20 Billion by 2031 at a CAGR of 23.5% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the synthetic biology market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market is driven by the increased funding for synthetic biology research, the declining cost of sequencing, the rising application area of synthetic biology, advancements in gene engineering technologies, and rising research on synthetic vaccines. However, biosafety and biosecurity issues and ethical issues associated with synthetic biology restrain market growth.

Furthermore, rising funding for R&D, a rising focus on personalized medicine, and innovations in synthetic biology are expected to offer growth opportunities. However, the unprecedented effect of synthetic organisms on ecosystems and public reluctance to accept and access synthetic biology are major challenges for the market's growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2024). The key players operating in the global synthetic biology market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), Novozymes A/S (Denmark), Codexis, Inc. (U.S.), Creative Biogene Inc. (U.S.), Amyris, Inc. (U.S.), Precigen, Inc. (U.S.), Illumina, Inc. (U.S.), New England Biolabs (U.S.), Ginkgo Bioworks (U.S.), Genscript Biotech Corp. (U.S.), Eurofins Scientific SE (France), and Twist Bioscience (U.S.).

Among all the products studied in this report, in 2024, the oligonucleotide and synthetic DNA segment is expected to account for the largest share of over 35% of the synthetic biology market. The expansion of the application of synthetic DNA and oligonucleotides across various end-use industries is contributing to the large market share of the segment. Also, the versatility and programmability of synthetic DNA and oligonucleotides are increasing their demand in biomedical research.

Among all the technologies studied in this report, in 2024, the gene synthesis segment is expected to account for the largest share of the synthetic biology market. The large share of gene synthesis is attributed to accelerated life sciences R&D and emerging application areas such as metabolic engineering. Gene synthesis technology simplifies the procedures of DNA synthesis by creating mutated, recombinant, or novel DNA sequences without a template, which otherwise would be a tedious task with traditional technologies, thus increasing the demand.

Among all the applications studied in this report, in 2024, the life science & healthcare application is expected to account for the largest share of over 41% of the synthetic biology market. Increasing funding for drug discovery & development is expected to accelerate the demand for synthetic biology tools for drug target identification & validation. For instance, in July 2022, the Council of Scientific and Industrial Research (CSIR) (India) invested USD 6.73 million in R&D activities for drug discovery and development. Additionally, increasing focus on synthetic vaccines and increasing funding for the development of immunotherapies is further contributing to the large market share of this segment.

Among all the end users studied in this report, in 2024, the pharmaceutical, biotechnology, & MedTech companies are expected to account for the largest share of the synthetic biology market. The increasing reliance of pharmaceutical & biotechnology, & MedTech companies on synthetic biology for developing IVD tests, optimizing production processes, and designing novel therapeutics is contributing to the large market share of this segment.

An in-depth analysis of the geographical scenario of the global synthetic biology market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region.

Among all the geographies studied in this report, in 2024, North America is expected to account for the largest share of over 36.8% of the synthetic biology market. The large share of this regional market is attributed to the growth in the life sciences sector, advancements in synthetic biology technologies, an increasing number of research studies in synthetic biology, government initiatives supporting research and development, rising demand for biofuel, and the presence of key market players.

Scope of the Report:

Synthetic Biology Market Assessment-by Product

• Oligonucleotide and Synthetic DNA
• Xeno-Nucleic Acids
• Enzymes
• Cloning Technologies Kits
• Chassis Organism
• Other Products

Note: Other products include synthetic cells, enabling kits, and viral expression systems

Synthetic Biology Market Assessment-by Technology

• Gene Synthesis
• Sequencing
• Genome Editing
• Cloning
• Site-directed Mutagenesis
• Bioinformatics
• Other Technologies

Note: Other technologies include nanotechnology, HTS, and microfluidics

Synthetic Biology Market Assessment-by Application

• Life Science & Healthcare Applications
  • Drug Discovery, Design & Development
  • Bioprocessing
  • Therapeutics
  • Other Life Sciences & Healthcare Applications
• Industrial & Chemical Applications
  • Biofuels
  • Industrial Enzyme, by End Use
• Textile
• Paper
• Cosmetics
• Bioplastics & Green Chemicals
• Food & Agriculture Applications
  • Specialty Foods
  • Fertilizers
• Environment Applications
  • Biosensing
  • Bioremediation/Conservation

Note: Other life sciences & healthcare applications include IVD test developments, personalized medicines, biomaterials

Synthetic Biology Market Assessment-by End User

• Pharmaceutical, Biotechnology, & MedTech Companies
• CMOs & CROs
• Academic & Research Institutes
• Food & Agriculture Industry
• Chemical Industry
• Environmental Agencies
• Other End Users

Note: Other end users include textile industry, paper industry, and cosmetics industry

Synthetic Biology Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Denmark
  • Switzerland
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Declining Cost of DNA Sequencing
  • 4.2.2. Rising Application Areas of Synthetic Biology
  • 4.2.3. Rising Research on Synthetic Vaccines
  • 4.2.4. Advancements in Gene Engineering Technologies
  • 4.2.5. Increased Funding for Synthetic Biology Research
• 4.3. Restraints
  • 4.3.1. Biosafety & Bio-Security Issue
  • 4.3.2. Ethical Issues Associated with Synthetic Biology
• 4.4. Opportunities
  • 4.4.1. Rising Funding for R&D
  • 4.4.2 Rising Focus on Personalized Medicine
  • 4.4.3. Innovations in Synthetic Biology
• 4.5. Challenges
  • 4.5.1. Unprecedented Effect of Synthetic Organisms on Ecosystem
  • 4.5.2. Public Reluctance for Acceptance and Access of Synthetic Biology
• 4.6. Factor Analysis
• 4.7. Trends
• 4.8. Regulatory Analysis
• 4.9. Porter's Five Force Analysis
• 4.10. Investment & Funding Scenario

5. Synthetic Biology Market Assessment-by Product

• 5.1. Overview
• 5.2. Oligonucleotide and Synthetic DNA
• 5.3. Xeno-nucleic Acids
• 5.4. Enzymes
• 5.5. Cloning Technology Kits
• 5.6. Chassis Organism
• 5.7. Other Products

6. Synthetic Biology Market Assessment-by Technology

• 6.1. Overview
• 6.2. Gene Synthesis
• 6.3. Sequencing
• 6.4. Genome Editing
• 6.5. Cloning
• 6.6. Site-directed Mutagenesis
• 6.7. Bioinformatics
• 6.8. Other Technologies

7. Synthetic Biology Market Assessment-by Application

• 7.1. Overview
• 7.2. Life Science & Healthcare Application
  • 7.2.1. Drug Discovery
  • 7.2.2. Bioprocessing
  • 7.2.3. Therapeutics
  • 7.2.4. Other Life Science & Healthcare Applications
• 7.3. Industrial & Chemical Application
  • 7.3.1. Biofuels
  • 7.3.2. Industrial Enzyme
    • 7.3.2.1. Textile Industry
    • 7.3.2.2. Paper Industry
    • 7.3.2.3. Cosmetic Industry
  • 7.3.3. Bioplastics & Green Chemicals
• 7.4. Food & Agriculture Application
  • 7.4.1. Specialty Food
  • 7.4.2. Fertilizers
• 7.5. Environment Application
  • 7.5.1. Biosensing
  • 7.5.2. Bioremediation/Conservation

8. Synthetic Biology Market Assessment-by End User

• 8.1. Overview
• 8.2. Pharmaceutical, Biotechnology, & MedTech Companies
• 8.3. CMOs & CROs
• 8.4. Academic & Research Institutes
• 8.5. Food & Agriculture Industry
• 8.6. Chemical Industry
• 8.7. Environmental Agencies
• 8.8. Other End Users

9. Synthetic Biology Market Assessment-by Geography

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Denmark
  • 9.3.7. Switzerland
  • 9.3.8. Rest of Europe (RoE)
• 9.4. Asia-Pacific
  • 9.4.1. Japan
  • 9.4.2. China
  • 9.4.3. India
  • 9.4.4. South Korea
  • 9.4.5. Australia
  • 9.4.6. Rest of Asia-Pacific (RoAPAC)
• 9.5. Latin America
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America (RoLATAM)
• 9.6. Middle East & Africa

10. Competition Analysis

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Competitive Dashboard
  • 10.4.1. Industry Leaders
  • 10.4.2. Market Differentiators
  • 10.4.3. Vanguards
  • 10.4.4. Emerging Companies
• 10.5. Market Share Analysis/Market Ranking, by Key Players (2023)

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

• 11.1. Thermo Fisher Scientific Inc.
• 11.2. Merck KGaA
• 11.3. Agilent Technologies, Inc.
• 11.4. Novozymes A/S
• 11.5. Codexis, Inc.
• 11.6. Creative Biogene Inc.
• 11.7. Amyris, Inc.
• 11.8. Precigen, Inc.
• 11.9. Illumina, Inc.
• 11.10. New England Biolabs
• 11.11. Ginkgo Bioworks
• 11.12. Genscript Biotech Corp.
• 11.13. Eurofins Scientific SE
• 11.14. Twist Bioscience

(Note: SWOT analysis of the top 5 companies will be provided.)

12. Appendix

• 12.1. Available Customization
• 12.2. Related Reports

관련자료